tiprankstipranks
Trending News
More News >

Defence Therapeutics’ AccuTOX Enhances Cancer Treatment

Defence Therapeutics’ AccuTOX Enhances Cancer Treatment

Defence Therapeutics (TSE:DTC) has released an update.

Confident Investing Starts Here:

Defence Therapeutics Inc. has announced that its AccuTOX® technology not only kills tumors but also boosts the immune system, significantly enhancing the effectiveness of Immune Checkpoint Inhibitors (ICI) in treating solid tumors. AccuTOX® achieves this by converting ‘cold’ tumors, which typically resist ICI treatment, into ‘hot’ tumors that are more vulnerable to immune attack. The company has observed a tenfold increase in treatment efficacy in preclinical studies and sees AccuTOX® as a potential game-changer for increasing the patient population eligible for ICI treatment.

For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1